In the SURPASS clinical trial program, participants treated with tirzepatide achieved HbA1c reductions of 1.8% to 2.4% from baseline, with many reaching glycemic targets
114,121 Gastrointestinal autonomic neuropathy Gastrointestinal autonomic neuropathy presents with various symptoms, such as esophageal dysmotility, gastroparesis, and enteropathy, including dysphagia, gastroesophageal reflux, delayed gastric emptying, diarrhea, constipation, and fecal incontinence
This legal and safety-focused approach protects you from counterfeit drugs while ensuring your therapy is medically appropriate for your individual health profile
But it did help with lowering sugar cravings